Tsunami Secures Majority Investment from Point72 Hyperscale
MENLO PARK, Calif.–(BUSINESS WIRE)–Point72 Hyperscale, the private equity strategy that uses applied artificial intelligence to…
Month: May 2022
Virax Biolabs Receives Ethical Approval for its Virax Immune COVID-19 Analytical Performance Study from the SBEBO Foundation for the Assessment of Ethics of Biomedical Research
Takes an Important Step Towards the Start of its Clinical Trial to Evaluate the Analytical…
Outlook Therapeutics to Participate at the Virtual Investor 2022 CEO Spotlight
Live moderated video webcast on Wednesday, May 11th at 1:00 PM ET ISELIN, N.J., May…
Celsion Corporation to Hold First Quarter 2022 Financial Results and Business Update Conference Call on Monday, May 16, 2022
LAWRENCEVILLE, N.J., May 09, 2022 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company…
Allogene Therapeutics Named 2022 Bay Area “Best Place to Work” by San Francisco Business Times and Silicon Valley Business Journal
Allogeneic CAR T Pioneer Highest Ranked Bay Area Biotech in the Large Company Category Based on…
Longeveron to Announce First Quarter 2022 Financial Results on May 13, 2022
Live conference call at 8:30 a.m. EST MIAMI, May 09, 2022 (GLOBE NEWSWIRE) — Longeveron…
Catalyst Biosciences Reports First Quarter 2022 Operating & Financial Results
SOUTH SAN FRANCISCO, Calif., May 09, 2022 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO)…
Albireo to Report Q1 2022 Financial Results on May 16
Conference call and webcast to be held at 4:30 pm ET BOSTON, May 09, 2022…
Acer Therapeutics Announces Agreement with FDA on Special Protocol Assessment for its Phase 3 EDSIVO™ (celiprolol) Trial in Vascular Ehlers-Danlos Syndrome Patients
Phase 3 DiSCOVER clinical trial initiation expected by end of Q2 2022 NEWTON, Mass., May…
Dyadic Announces Successful Toxicology Data Published in “Toxicologic Pathology”
Toxicology data published in the international peer-reviewed scientific journal “Toxicologic Pathology” demonstrates excellent safety profile…
Finch Therapeutics to Host Corporate Update Conference Call and Webcast on May 16, 2022
SOMERVILLE, Mass., May 09, 2022 (GLOBE NEWSWIRE) — Finch Therapeutics Group, Inc. (“Finch” or “Finch…
Spero Therapeutics to Provide Business Update and Report First Quarter 2022 Financial Results on Monday, May 16, 2022
CAMBRIDGE, Mass., May 09, 2022 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO) today announced that…
Mainz Biomed to Host Key Opinion Leader Event at DDW 2022
Digestive Disease Week is the largest international gathering of physicians, researchers and academics in the…
Impel Pharmaceuticals to Report First Quarter 2022 Financial Results on Monday, May 16, 2022
SEATTLE, May 09, 2022 (GLOBE NEWSWIRE) — Impel Pharmaceuticals Inc. (NASDAQ: IMPL), a commercial-stage pharmaceutical company…
Kala Pharmaceuticals to Report First Quarter 2022 Financial Results and Host Conference Call
ARLINGTON, Mass., May 09, 2022 (GLOBE NEWSWIRE) — Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical…
Ascendis Pharma A/S to Participate in the BofA Securities 2022 Healthcare Conference
COPENHAGEN, Denmark, May 09, 2022 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) announced today…
Humacyte to Provide Human Acellular Vessels™ (HAVs™) to Front-line Hospitals in Ukraine for Treatment of Vascular Trauma Injuries
— First shipment of HAVs to six Ukrainian hospitals made today — — Product candidate…
Imago BioSciences Announces First Participant Dosed in Investigator-Sponsored Study of Bomedemstat in Combination with Atezolizumab in Small Cell Lung Cancer
SOUTH SAN FRANCISCO, Calif., May 09, 2022 (GLOBE NEWSWIRE) — Imago BioSciences, Inc. (“Imago”) (Nasdaq: IMGO),…
Immix Biopharma Announces Share Repurchase Program
Immix Biopharma Announces Share Repurchase Program Immix Biopharma, Inc. (NASDAQ:IMMX) LOS ANGELES, May 09, 2022…
Alimera Sciences Reports First Quarter 2022 Results
Consolidated Net Revenue of $11.9 Million Up 6% vs. First Quarter of 2021 U.S. Net…